Piper Sandler Companies is gaining traction with a recovering market. Find out why PIPR stock is becoming an attractive ...

Piper Sandler dipped into the beverage sector on Tuesday by issuing new Overweight ratings on Coca-Cola ( NYSE: KO) and ...

Fintel reports that on January 8, 2025, Piper Sandler upgraded their outlook for Arthur J. Gallagher (NYSE:AJG) from Neutral ...

Fintel reports that on January 8, 2025, Piper Sandler initiated coverage of Norwood Financial (NasdaqGM:NWFL) with a Neutral ...

Despite recent share appreciation, Piper Sandler believes there is still significant upside for Kenvue. “Though shares have ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on TransMedics Group (TMDX – Research Report) today and set a price target of ...

In a report released today, Charles Neivert from Piper Sandler maintained a Sell rating on Albemarle (ALB – Research Report), with a price ...

Piper Sandler initiated coverage on soda stocks, rating PepsiCo (NASDAQ:PEP), Coca-Cola (NYSE:KO) “overweight,” and Neutral on Keurig Dr Pepper (NASDAQ:KDP).

An increase in construction spending in November was too small to change a flattening trend, Piper Sandler economists write.

On Friday, Piper Sandler confirmed its Overweight rating on Guardant Health (NASDAQ:GH) shares with a steady price target of $34.00. This aligns with broader analyst sentiment, as InvestingPro ...

Fintel reports that on January 2, 2025, Piper Sandler downgraded their outlook for Biogen (WBAG:BIIB) from Overweight to Neutral. There are 1,768 funds or institutions reporting positions in Biogen.